Premium
Update on the development of molecular imaging and nanomedicine in China: Optical imaging
Author(s) -
Wu Lina,
Zou Hongyan,
Wang Hongbin,
Zhang Sihang,
Liu Shuang,
Jiang Ying,
Chen Jing,
Li Yingbo,
Shao Mengping,
Zhang Ruixin,
Li Xiaona,
Dong Jing,
Yang Lili,
Wang Kai,
Zhu Xinyuan,
Sun Xilin
Publication year - 2020
Publication title -
wiley interdisciplinary reviews: nanomedicine and nanobiotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.175
H-Index - 72
eISSN - 1939-0041
pISSN - 1939-5116
DOI - 10.1002/wnan.1660
Subject(s) - nanomedicine , biochemist , china , molecular imaging , engineering ethics , medicine , optical imaging , medical imaging , medical physics , data science , nanotechnology , political science , computer science , engineering , artificial intelligence , microbiology and biotechnology , biology , materials science , physics , optics , nanoparticle , law , biochemical engineering , in vivo
Abstract Molecular imaging has received increased attention worldwide, including in China, because it offers noninvasive characterization of widely diverse clinically significant pathologies. To achieve these goals, nanomedicine has evolved into a broad interdisciplinary field with flexible designs to accommodate and concentrate imaging and therapeutic payloads into pathological cells through selective binding to disease specific cell membrane biomarkers. This concept of personalized medicine reflects the vision of “magic bullets” proposed by German biochemist Paul Ehrlich over 100 years ago. As happening worldwide, Chinese scientists are contributing to this tsunami of science and technologies through impactful national programs and international research collaborations. This review provides a comprehensive update of Chinese innovations to address intractable unmet medical need in China and worldwide in the optical sciences. This article is categorized under: Diagnostic Tools > in vivo Nanodiagnostics and Imaging